Virginia Belsúe

788 total citations · 1 hit paper
16 papers, 577 citations indexed

About

Virginia Belsúe is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Virginia Belsúe has authored 16 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Virginia Belsúe's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). Virginia Belsúe is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). Virginia Belsúe collaborates with scholars based in Spain, United States and United Kingdom. Virginia Belsúe's co-authors include Pedro Berraondo, Maite Álvarez, Ignacio Melero, Itziar Otano, Vanesa de Luque, Álvaro Teijeira, Carlos de Andrea, María E. Rodríguez-Ruiz, Martina Álvarez and José Luis Perez‐Gracia and has published in prestigious journals such as Nature, The Journal of Immunology and Hepatology.

In The Last Decade

Virginia Belsúe

16 papers receiving 572 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

2019 323 citations Elísabeth Pérez-Ruiz, Luna Minute et al. Nature profile →

Peers

Countries citing papers authored by Virginia Belsúe

Since Specialization

Citations

This map shows the geographic impact of Virginia Belsúe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Belsúe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Belsúe more than expected).

Fields of papers citing papers by Virginia Belsúe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Belsúe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Belsúe. The network helps show where Virginia Belsúe may publish in the future.

Co-authorship network of co-authors of Virginia Belsúe

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Belsúe. A scholar is included among the top collaborators of Virginia Belsúe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Belsúe. Virginia Belsúe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis 2025 ·Journal of Nanobiotechnology ·(unknown), (unknown), Myriam Fernández-Sendin, (unknown), (unknown), (unknown), (unknown), Virginia Belsúe, (unknown), Sara Zalba, (unknown), Marı́a J. Garrido, Ignacio Melero, Fernando Aranda, Pedro Berraondo	1
2	Intratumoral administration of Hibiscus sabdariffa-derived anthocyanins exerts potent antitumor effects in murine cancer models 2025 ·Frontiers in Immunology ·(unknown), Juan Florencio Gómez-Leyva, (unknown), (unknown), (unknown), Noëlia Casares, (unknown), (unknown), F. Hernández, (unknown), (unknown), (unknown), (unknown), Virginia Belsúe, Fernando Aranda, Pedro Berraondo, Maritza Roxana García-García	2
3	Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth 2025 ·Frontiers in Immunology ·(unknown), Sara Zalba, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Virginia Belsúe, (unknown), (unknown), (unknown), Fernando Aranda, Marı́a J. Garrido, Pedro Berraondo	1
4	Tumor slice culture system for ex vivo immunotherapy studies 2024 ·Methods in cell biology ·(unknown), (unknown), Virginia Belsúe, Pedro Berraondo, Ignacio Melero, Fernando Aranda	1
5	Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice 2021 ·Frontiers in Pharmacology ·(unknown), (unknown), Marcos Vásquez, (unknown), Myriam Fernández-Sendin, (unknown), Virginia Belsúe, Javier Escalada, Werner Ulrich, Norbert Tennagels, Pedro Berraondo	5
6	Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1 2021 ·British Journal of Cancer ·Sara Zalba, Virginia Belsúe, Brian Topp, Dinesh de Alwis, Maite Álvarez, Iñaki F. Trocóniz, Pedro Berraondo, Marı́a J. Garrido	6
7	Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor 2021 ·Biomedicines ·Teresa Lozano, Noëlia Casares, (unknown), (unknown), Marta Gorraiz, Jonathan Parker, Marta Ruiz, Virginia Belsúe, Antonio Pineda‐Lucena, Julen Oyarzábal, Juan José Lasarte	7
8	Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy breakdown → 2019 ·Nature ·Elísabeth Pérez-Ruiz, Luna Minute, Itziar Otano, Maite Álvarez, María C. Ochoa, Virginia Belsúe, Carlos de Andrea, María E. Rodríguez-Ruiz, José Luis Perez‐Gracia, Iván Márquez‐Rodas, Casilda Llácer, Martina Álvarez, Vanesa de Luque, Carmen Molina, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero	323
9	Immune monitoring of immunosuppression withdrawal of liver transplant recipients 2015 ·Transplant Immunology ·Rocío García de la Garza, Pablo Sarobe, Juana Merino, Juan José Lasarte, Delia D’Avola, Virginia Belsúe, (unknown), Leyre Silva, Mercedes Iñarrairaegui, Bruno Sangro, Iosu Sola, F. Pardo, Jorge Quiroga, J.I. Herrero	19
10	Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination 2015 ·OncoImmunology ·Diana Llópiz, Fernando Aranda, Nancy Díaz‐Valdés, Marta Ruiz, (unknown), Virginia Belsúe, Juan José Lasarte, Pablo Sarobe	18
11	Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation 2015 ·The Journal of Immunology ·Teresa Lozano, Lorea Villanueva, (unknown), Marta Gorraiz, Marta Ruiz, Virginia Belsúe, José Ignacio Riezu‐Boj, Sandra Hervás‐Stubbs, Julen Oyarzábal, Hozefa S. Bandukwala, Ana Rita Lourenço, Paul J. Coffer, Pablo Sarobe, Jesús Prìeto, Noëlia Casares, Juan José Lasarte	52
12	Helper cell-independent antitumor activity of potent CD8⁺T cell epitope peptide vaccines is dependent upon CD40L 2013 ·OncoImmunology ·Diana Llópiz, Eduardo Huarte, Marta Ruiz, Jaione Bezunartea, Virginia Belsúe, Aintzane Zabaleta, Juan José Lasarte, Jesús Prìeto, Francisco Borrás‐Cuesta, Pablo Sarobe	3
13	Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance 2013 ·Liver Transplantation ·Rocío García de la Garza, Pablo Sarobe, Juana Merino, Juan José Lasarte, Delia D’Avola, Virginia Belsúe, (unknown), Leyre Silva, Mercedes Iñarrairaegui, Bruno Sangro, J. Solà, Fernando Pardo, Jorge Quiroga, J.I. Herrero	70
14	Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis 2010 ·Vaccine ·(unknown), Catherine Fayolle, Noëlia Casares, Virginia Belsúe, José Ignacio Riezu‐Boj, Pablo Sarobe, Jesús Prìeto, Francisco Borrás‐Cuesta, Claude Leclerc, Juan José Lasarte	8
15	Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10 2010 ·Hepatology ·Nancy Díaz‐Valdés, Lorea Manterola, Virginia Belsúe, José Ignacio Riezu‐Boj, Esther Larrea, (unknown), Diana Llópiz, Jacinto López‐Sagaseta, Hervé Lerat, Jean–Michel Pawlotsky, Jesús Prìeto, Juan José Lasarte, Francisco Borrás‐Cuesta, Pablo Sarobe	23
16	Determination of chloroanisole compounds in red wine by headspace solid-phase microextraction and gas chromatography–mass spectrometry 2004 ·Journal of Chromatography A ·Elena Lizarraga, (unknown), Virginia Belsúe, Elena González‐Peñas	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact